These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 31621311)
1. Streamlined Characterization of an Antibody-Drug Conjugate by Two-Dimensional and Four-Dimensional Liquid Chromatography/Mass Spectrometry. Goyon A; Kim M; Dai L; Cornell C; Jacobson F; Guillarme D; Stella C Anal Chem; 2019 Dec; 91(23):14896-14903. PubMed ID: 31621311 [TBL] [Abstract][Full Text] [Related]
2. [The Characterization of Drug-to-Antibody Ratio and Isoforms of ADCs Using LC and MS Technologies]. Iizuka R; Kotch F; Xu A; Porter T; Shion H; Birdsall R; Chen W Yakugaku Zasshi; 2017; 137(5):525-528. PubMed ID: 28458283 [TBL] [Abstract][Full Text] [Related]
3. A native SEC-MS workflow and validation for analyzing drug-to-antibody ratio and drug load distribution in cysteine-linked antibody-drug conjugates. Wu G; Yu C; Yin S; Du J; Zhang Y; Fu Z; Wang L; Wang J J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jul; 1241():124167. PubMed ID: 38823148 [TBL] [Abstract][Full Text] [Related]
4. A rapid on-line method for mass spectrometric confirmation of a cysteine-conjugated antibody-drug-conjugate structure using multidimensional chromatography. Birdsall RE; Shion H; Kotch FW; Xu A; Porter TJ; Chen W MAbs; 2015; 7(6):1036-44. PubMed ID: 26305867 [TBL] [Abstract][Full Text] [Related]
5. Two-Dimensional Liquid Chromatography Coupled to High-Resolution Mass Spectrometry for the Analysis of ADCs. Chapel S; Rouvière F; Sarrut M; Heinisch S Methods Mol Biol; 2020; 2078():163-185. PubMed ID: 31643056 [TBL] [Abstract][Full Text] [Related]
6. A Combination of Native LC-MS Approaches for the Comprehensive Characterization of the Antibody-Drug Conjugate Trastuzumab Deruxtecan. Deslignière E; Diemer H; Erb S; Coliat P; Pivot X; Detappe A; Hernandez-Alba O; Cianférani S Front Biosci (Landmark Ed); 2022 Oct; 27(10):290. PubMed ID: 36336868 [TBL] [Abstract][Full Text] [Related]
7. An Online Four-Dimensional HIC×SEC-IM×MS Methodology for Proof-of-Concept Characterization of Antibody Drug Conjugates. Ehkirch A; D'Atri V; Rouviere F; Hernandez-Alba O; Goyon A; Colas O; Sarrut M; Beck A; Guillarme D; Heinisch S; Cianferani S Anal Chem; 2018 Feb; 90(3):1578-1586. PubMed ID: 29260862 [TBL] [Abstract][Full Text] [Related]
8. Innovative native MS methodologies for antibody drug conjugate characterization: High resolution native MS and IM-MS for average DAR and DAR distribution assessment. Debaene F; Boeuf A; Wagner-Rousset E; Colas O; Ayoub D; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S Anal Chem; 2014 Nov; 86(21):10674-83. PubMed ID: 25270580 [TBL] [Abstract][Full Text] [Related]
9. Characterization of drug load variants in a thiol linked antibody-drug conjugate using multidimensional chromatography. Gilroy JJ; Eakin CM J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():182-189. PubMed ID: 28622622 [TBL] [Abstract][Full Text] [Related]
10. Drug-to-antibody ratio (DAR) and drug load distribution by hydrophobic interaction chromatography and reversed phase high-performance liquid chromatography. Ouyang J Methods Mol Biol; 2013; 1045():275-83. PubMed ID: 23913154 [TBL] [Abstract][Full Text] [Related]
11. A size exclusion-reversed phase two dimensional-liquid chromatography methodology for stability and small molecule related species in antibody drug conjugates. Li Y; Gu C; Gruenhagen J; Zhang K; Yehl P; Chetwyn NP; Medley CD J Chromatogr A; 2015 May; 1393():81-8. PubMed ID: 25818558 [TBL] [Abstract][Full Text] [Related]
12. Hydrophobic interaction chromatography (HIC) method development and characterization of resolved drug-load variants in site-specifically conjugated pyrrolobenzodiazepine dimer-based antibody drug conjugates (PBD-ADCs). Janaratne T; Wang XC; Becker C; Zhao Y; Leanna R; Pritts W J Pharm Biomed Anal; 2020 Feb; 179():113027. PubMed ID: 31830625 [TBL] [Abstract][Full Text] [Related]
13. Analysis of ADCs by Native Mass Spectrometry. Hernandez-Alba O; Ehkirch A; Beck A; Cianférani S Methods Mol Biol; 2020; 2078():197-211. PubMed ID: 31643058 [TBL] [Abstract][Full Text] [Related]
14. High-throughput oxidation screen of antibody-drug conjugates by analytical protein A chromatography following IdeS digest. Buecheler JW; Winzer M; Weber C; Gieseler H J Pharm Pharmacol; 2018 May; 70(5):625-635. PubMed ID: 29380379 [TBL] [Abstract][Full Text] [Related]
15. Characterization of antibody drug conjugate positional isomers at cysteine residues by peptide mapping LC-MS analysis. Janin-Bussat MC; Dillenbourg M; Corvaia N; Beck A; Klinguer-Hamour C J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Feb; 981-982():9-13. PubMed ID: 25596378 [TBL] [Abstract][Full Text] [Related]
16. Accurate determination of drug-to-antibody ratio of interchain cysteine-linked antibody-drug conjugates by LC-HRMS. Li K; Zhang Z; Lin ZJ; Shi H; Ma Y Anal Bioanal Chem; 2020 Feb; 412(4):833-840. PubMed ID: 31872274 [TBL] [Abstract][Full Text] [Related]
17. Native size-exclusion chromatography-mass spectrometry: suitability for antibody-drug conjugate drug-to-antibody ratio quantitation across a range of chemotypes and drug-loading levels. Jones J; Pack L; Hunter JH; Valliere-Douglass JF MAbs; 2020; 12(1):1682895. PubMed ID: 31769727 [TBL] [Abstract][Full Text] [Related]
18. Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. I - Optimization of separation conditions. Sarrut M; Corgier A; Fekete S; Guillarme D; Lascoux D; Janin-Bussat MC; Beck A; Heinisch S J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():103-111. PubMed ID: 27426266 [TBL] [Abstract][Full Text] [Related]
19. Antibody-drug conjugate model fast characterization by LC-MS following IdeS proteolytic digestion. Wagner-Rousset E; Janin-Bussat MC; Colas O; Excoffier M; Ayoub D; Haeuw JF; Rilatt I; Perez M; Corvaïa N; Beck A MAbs; 2014; 6(1):273-85. PubMed ID: 24135617 [TBL] [Abstract][Full Text] [Related]
20. Immunoprecipitation middle-up LC-MS for in vivo drug-to-antibody ratio determination for antibody-drug conjugates. Davis JA; Kagan M; Read J; Walles M; Hatsis P Bioanalysis; 2017 Oct; 9(20):1535-1549. PubMed ID: 29072490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]